U.S. STOCKS ON THE MOVE-Thermo Fisher, CME, Capital One, Northern Trust
U.S. STOCKS ON THE MOVE-Thermo Fisher, CME
U.S. STOCKS ON THE MOVE-Wabtec, Robinhood, NANO Nuclear Energy
U.S. STOCKS ON THE MOVE-SpaceX, Elevance, Netflix
Disc Medicine down after $450 mln equity raise following rare disease drug trial success
Brief: Disc Medicine Announces Pricing Of $450 Million Upsized Public Offering Of Common Stock
US RESEARCH ROUNDUP-Axon Enterprise, Williams-Sonoma, Xcel Energy
Brief: Disc Medicine Announces Proposed $350 Million Public Offering Of Common Stock And Pre-Funded Warrants
Disc Medicine dips after launching $350 mln stock offering
US STOCKS ON THE MOVE-CoreWeave, Moderna, Datadog
Disc Medicine's late-stage win clears path for approval of sun-allergy pill (updated)
U.S. STOCKS ON THE MOVE-Amazon, CoreWeave, Moderna
U.S. STOCKS ON THE MOVE-Centrus Energy, Disc Medicine, Crypto
Disc Medicine's rare disease drug succeeds in late-stage trial
Disc Medicine soars as rare disease drug aces key trial
Brief: Disc Medicine Announces Success On All Primary And Secondary Endpoints In The Pivotal Phase 3 Apollo Trial Of Bitopertin In Adults And Adolescents With Erythropoietic Protoporphyria (Epp)
NASDAQ RESUMED AT 07:25 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Disc Medicine posts smaller-than-expected Q2 net loss